# FDA Inspection 960817 - West Texas Cancer Center -Texas Oncology, PA - February 17, 2016

Source: https://www.keypedia.com/records/fda_inspections/west-texas-cancer-center-texas-oncology-pa/e579dff4-1c9e-496e-9a53-ed7c1534159f
Source feed: FDA_Inspections

> FDA Inspection 960817 for West Texas Cancer Center -Texas Oncology, PA on February 17, 2016. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 960817
- Company Name: West Texas Cancer Center -Texas Oncology, PA
- Inspection Date: 2016-02-17
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 849358 - 2013-09-19](https://www.keypedia.com/records/fda_inspections/west-texas-cancer-center-texas-oncology-pa/0e1d8b1a-322e-4049-aef0-12d4d5e4197d)
- [FDA Inspection 710568 - 2011-02-01](https://www.keypedia.com/records/fda_inspections/west-texas-cancer-center-texas-oncology-pa/eb61c0b1-1f4e-4423-934a-f803285a0d6e)

Company: https://www.keypedia.com/companies/west-texas-cancer-center-texas-oncology-pa/f46aca16-2980-44e1-8d38-bdefa316b708

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d